Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-129849
Filing Date
2025-05-29
Accepted
2025-05-29 06:02:26
Documents
42
Period of Report
2025-05-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d907074d8ka.htm   iXBRL 8-K/A 31647
2 EX-99.1 d907074dex991.htm EX-99.1 35675
3 EX-99.2 d907074dex992.htm EX-99.2 43745
7 GRAPHIC g904503ex99_2p10g1.jpg GRAPHIC 462331
8 GRAPHIC g904503ex99_2p11g1.jpg GRAPHIC 400765
9 GRAPHIC g904503ex99_2p12g1.jpg GRAPHIC 175350
10 GRAPHIC g904503ex99_2p13g1.jpg GRAPHIC 410303
11 GRAPHIC g904503ex99_2p14g1.jpg GRAPHIC 374147
12 GRAPHIC g904503ex99_2p15g1.jpg GRAPHIC 119825
13 GRAPHIC g904503ex99_2p16g1.jpg GRAPHIC 382445
14 GRAPHIC g904503ex99_2p17g1.jpg GRAPHIC 446890
15 GRAPHIC g904503ex99_2p18g1.jpg GRAPHIC 506735
16 GRAPHIC g904503ex99_2p19g1.jpg GRAPHIC 380236
17 GRAPHIC g904503ex99_2p1g1.jpg GRAPHIC 367398
18 GRAPHIC g904503ex99_2p20g1.jpg GRAPHIC 334343
19 GRAPHIC g904503ex99_2p21g1.jpg GRAPHIC 327498
20 GRAPHIC g904503ex99_2p22g1.jpg GRAPHIC 293454
21 GRAPHIC g904503ex99_2p23g1.jpg GRAPHIC 287026
22 GRAPHIC g904503ex99_2p24g1.jpg GRAPHIC 313018
23 GRAPHIC g904503ex99_2p25g1.jpg GRAPHIC 390780
24 GRAPHIC g904503ex99_2p26g1.jpg GRAPHIC 326948
25 GRAPHIC g904503ex99_2p27g1.jpg GRAPHIC 63928
26 GRAPHIC g904503ex99_2p28g1.jpg GRAPHIC 686521
27 GRAPHIC g904503ex99_2p2g1.jpg GRAPHIC 598493
28 GRAPHIC g904503ex99_2p3g1.jpg GRAPHIC 149877
29 GRAPHIC g904503ex99_2p4g1.jpg GRAPHIC 474070
30 GRAPHIC g904503ex99_2p5g1.jpg GRAPHIC 167487
31 GRAPHIC g904503ex99_2p6g1.jpg GRAPHIC 342242
32 GRAPHIC g904503ex99_2p7g1.jpg GRAPHIC 499592
33 GRAPHIC g904503ex99_2p8g1.jpg GRAPHIC 402284
34 GRAPHIC g904503ex99_2p9g1.jpg GRAPHIC 381957
  Complete submission text file 0001193125-25-129849.txt   14128268

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsha-20250528.xsd EX-101.SCH 2845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsha-20250528_lab.xml EX-101.LAB 19445
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsha-20250528_pre.xml EX-101.PRE 12138
44 EXTRACTED XBRL INSTANCE DOCUMENT d907074d8ka_htm.xml XML 4393
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39536 | Film No.: 25997532
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)